Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alyssa R Merkel

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|July 2, 2021
Biphasic α2β1 Integrin Expression in Breast Cancer Metastasis to BoneMilene N O Moritz, Alyssa R Merkel, Ean G Feldman, et al.
Bone|May 14, 2018
Early TGF-β inhibition in mice reduces the incidence of breast cancer induced bone disease in a myeloid dependent mannerDenise Buenrostro, Kristin A Kwakwa, Nicole E Putnam, et al.
Bone|July 18, 2016
Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone diseaseJeffry S Nyman, Alyssa R Merkel, Sasidhar Uppuganti, et al.
Bonekey Reports|April 25, 2015
Predicting mouse vertebra strength with micro-computed tomography-derived finite element analysisJeffry S Nyman, Sasidhar Uppuganti, Alexander J Makowski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 17, 2017
Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic SwitchPatrick L Mulcrone, J Preston Campbell, Lise Clément-Demange, et al.
Biomaterials|June 27, 2015
Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin β3 and TGF-β receptor type IIJonathan M Page, Alyssa R Merkel, Nazanin S Ruppender, et al.
Data in Brief|August 26, 2015
Altering adsorbed proteins or cellular gene expression in bone-metastatic cancer cells affects PTHrP and Gli2 without altering cell growthJonathan M Page, Alyssa R Merkel, Nazanin S Ruppender, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 9, 2019
Systemic delivery of a Gli inhibitor via polymeric nanocarriers inhibits tumor-induced bone diseaseJoseph P Vanderburgh, Kristin A Kwakwa, Thomas A Werfel, et al.
Cancer Research|December 30, 2010
TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signalingRachelle W Johnson, Mai P Nguyen, Susan S Padalecki, et al.
JBMR Plus|April 19, 2021
EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic DiseaseDavid B Vaught, Alyssa R Merkel, Conor C Lynch, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|July 2, 2021
Biphasic α2β1 Integrin Expression in Breast Cancer Metastasis to BoneMilene N O Moritz, Alyssa R Merkel, Ean G Feldman, et al.
Bone|May 14, 2018
Early TGF-β inhibition in mice reduces the incidence of breast cancer induced bone disease in a myeloid dependent mannerDenise Buenrostro, Kristin A Kwakwa, Nicole E Putnam, et al.
Bone|July 18, 2016
Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone diseaseJeffry S Nyman, Alyssa R Merkel, Sasidhar Uppuganti, et al.
Bonekey Reports|April 25, 2015
Predicting mouse vertebra strength with micro-computed tomography-derived finite element analysisJeffry S Nyman, Sasidhar Uppuganti, Alexander J Makowski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 17, 2017
Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic SwitchPatrick L Mulcrone, J Preston Campbell, Lise Clément-Demange, et al.
Biomaterials|June 27, 2015
Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin β3 and TGF-β receptor type IIJonathan M Page, Alyssa R Merkel, Nazanin S Ruppender, et al.
Data in Brief|August 26, 2015
Altering adsorbed proteins or cellular gene expression in bone-metastatic cancer cells affects PTHrP and Gli2 without altering cell growthJonathan M Page, Alyssa R Merkel, Nazanin S Ruppender, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 9, 2019
Systemic delivery of a Gli inhibitor via polymeric nanocarriers inhibits tumor-induced bone diseaseJoseph P Vanderburgh, Kristin A Kwakwa, Thomas A Werfel, et al.
Cancer Research|December 30, 2010
TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signalingRachelle W Johnson, Mai P Nguyen, Susan S Padalecki, et al.
JBMR Plus|April 19, 2021
EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic DiseaseDavid B Vaught, Alyssa R Merkel, Conor C Lynch, et al.
Pageof 3